SHH and medulloblastoma: On another note, with the increased interest in epigenetics and their utility in cancer therapeutics, epigenetic profiling of SHH-driven medulloblastomas exhibited an increased expression of the miR17~92 polycitron in this subgroup and a synergistic effect between this overexpression and the SHH pathway to augment the growth of cancer cells [95].